InvestorsHub Logo
Followers 3349
Posts 85758
Boards Moderated 5
Alias Born 10/05/2005

Re: None

Thursday, 02/23/2006 7:21:11 AM

Thursday, February 23, 2006 7:21:11 AM

Post# of 1232
ATLANTA--(Business Wire)--Feb. 23, 2006--
Nova BioGenetics, Inc. (OTC: NVBG), a U.S. antimicrobial
manufacturer, announces that the platform for success in both European
and other global markets has been established through our U.K.
regional office. We are now working closely with an extensive network
of national and international companies operating in a wide range of
industries and markets.
Following successful product trials, we have just received our
first order from a leading Turkish supplier of antimicrobial and
chemical products. This company is initially looking to supply our
antimicrobial to its existing global customer base in the Textile
Industry. Further applications have also been identified for testing
by this supplier for four other industries. Technical support for our
Turkish colleagues is being provided by our specialist staff in
Atlanta.
Additional progress has also been made with regard to our European
manufacturing and blending capability. Nova is working with a major
U.K. manufacturing and blending company that has excellent technical
support facilities and a comprehensive distribution network. This
relationship strengthens the capacity to meet all foreseeable demand
for our products in Europe, the Middle East and Asia.
Designed specifically for lower volume needs, the ability to shop
online for Nova products in multiple specialty markets will soon
become available through Nova's North American and European subsidiary
website, presently under construction,
(www.novaspecialtychemicals.com).
NVBG reminds all shareholders to review the company's filings with
the SEC to determine the investment opportunity in the company's
stock.

Overview: Nova is a U.S. based antimicrobial manufacturer. From an
expanding global infrastructure, Nova is providing solutions to
today's market demand for a mold, mildew, bacteria and virus free
environment. Nova's portfolio of patented and EPA approved
antimicrobial solutions has allowed them to find unique and growing
opportunities in multiple industries.
Further information on NVBG and its line of products can be found
by visiting www.novabiogenetics.com, www.novaspecialtychemicals.com or
by calling 770-650-6508.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.